INS and type 2 diabetes mellitus: In the smaller study, 34 adults with type 2 diabetes (mean age 55 years) were assigned to two smart speaker interventions: (1) “standard of care” daily prompts to maintain a log of insulin and blood glucose, or (2) “conversational AI,” in which patients reported their insulin use and blood glucose levels to the smart speaker and received AI-generated dosing instructions based on the data they had just reported [21].